SIGN UP
LOG IN
T
TSHA
Taysha Gene Therapies, Inc.
2.60
0.20+8.09%Opening13:03 05/02 EDT
OPEN/PREV CLOSE2.490/2.410
TODAY RANGE2.440-2.725
VOL3.76M
MARKET CAP534.17M
52 WEEK RANGE1.050-4.320
AVG VOL (3M)2.18M
% TURNOVER1.83%
TURNOVER--
P/E (TTM)-7.2969
% RANGE11.83%
EPS(TTM)-0.3570
P/E(FORWARD)-7.4429
P/B7.46
BVPS0.3490
DIVIDEND--
P/S64.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP436.19M
SHARES OUTSTANDING205.05M
NEXT EARNINGS05/12-05/16
FREE FLOAT167.45M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/25 15:55
Biotech Alert: Searches spiking for these stocks today
Seeking Alpha·04/21 14:00
Pz-Cel Has Massive Potential For RDEB Patients
Seeking Alpha·04/15 20:04
Taysha Gene Therapies: Sell Rating On Uncertain Pipeline Prospects And Limited Opportunity
Dow Jones·04/10 11:40
Taysha Gene Therapies Price Target Maintained With a $6.00/Share by Needham
Benzinga·04/10 11:30
Needham Reiterates Buy on Taysha Gene Therapies, Maintains $6 Price Target
TipRanks·04/10 10:49
Needham Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.